Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 14/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 12/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 12/20 | 0.50 |
| ▸ | MEN1 | O00255 | 10/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 10/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 10/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | USP2 | O75604 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6847836 | 0.89 | CLK4 (0.44) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL29619599 | 0.79 | CYP1A2 (0.42) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL10142592 | 0.78 | HTR7 (0.44) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL21670474 | 0.77 | CYP1A2 (0.42) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL25733803 | 0.77 | CYP1A2 (0.51) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL16431002 | 0.77 | CYP1A2 (0.51) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL25719745 | 0.77 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL28657158 | 0.76 | NT5E (0.45) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| SCHEMBL2099096 | 0.76 | KDM4E (0.52) | CYP1A2CYP2D6CYP3A4MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL25229590 | 0.76 | CYP1A2 (0.50) | CYP1A2CYP2D6CYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022208382-A1 | NOVEL DIALKOXYNAPHTHO[2,3-C]FURAN-1(3H)-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE OR SARS-COV-2 INFECTION DISEASE, COMPRISING SAME | 동화약품주식회사 | 2022-10-06 | — | — | WO | claimed |
| CN-115181095-B | Pyrimidine-based luminophore with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof | 天津大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-112585184-B | Method for reducing aldehyde emissions in polyurethane foams | 陶氏环球技术有限责任公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-115181095-A | Pyrimidine-based luminophor with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof | 天津大学 | 2022-10-14 | — | — | CN | disclosed |
| WO-2022208382-A1 | NOVEL DIALKOXYNAPHTHO[2,3-C]FURAN-1(3H)-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE OR SARS-COV-2 INFECTION DISEASE, COMPRISING SAME | 동화약품주식회사 | 2022-10-06 | — | — | WO | disclosed |
| CN-114585618-A | Fluorine-containing pyrimidine compound and method for producing same | 优迈特株式会社 | 2022-06-03 | — | — | CN | disclosed |
| CN-114555566-A | Organic compound and organic electroluminescent element comprising same | 索路思高新材料有限公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-3555095-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018157830-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-09-07 | — | — | WO | disclosed |
| EP-3362451-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2018-08-22 | — | — | EP | disclosed |
| WO-2018127096-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-07-12 | — | — | WO | disclosed |
| WO-2018108125-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-06-21 | — | — | WO | disclosed |
| WO-2017097234-A1 | INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2017-06-15 | — | — | WO | disclosed |